Literature DB >> 15953075

Treatment of small plaque parapsoriasis with narrow-band (311 nm) ultraviolet B: a retrospective study.

T Herzinger1, K Degitz, G Plewig, M Röcken.   

Abstract

Narrow band (311 nm) ultraviolet B (NB-UVB) has been shown to be a safe and effective treatment for psoriasis and other inflammatory skin diseases. We have therefore employed NB-UVB in the treatment of small plaque parapsoriasis (SPP) since 1996. All patients (16/16) responded with complete remission of the disease after a mean number of 32.8 exposures and a mean total dose of 35.4 J/cm2. Unwanted side-effects were rare (3.3%) and always mild. Relapse of the disease occurred after an average of 29 weeks in those patients who came for follow-up visits. Therefore, NB-UVB is an effective, comparably safe and convenient alternative to psoralen and ultraviolet A therapy or other treatment modalities in the suppression of SPP.

Entities:  

Mesh:

Year:  2005        PMID: 15953075     DOI: 10.1111/j.1365-2230.2005.01752.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  3 in total

Review 1.  Phototherapy in dermatological maladies (Review).

Authors:  Daciana Elena Branisteanu; Diana Stefania Dirzu; Mihaela Paula Toader; Daniel Constantin Branisteanu; Alin Codrut Nicolescu; Ilarie Brihan; Camelia Margareta Bogdanici; George Branisteanu; Andreea Dimitriu; Nicoleta Anton; Elena Andrese Porumb
Journal:  Exp Ther Med       Date:  2022-02-03       Impact factor: 2.447

Review 2.  Parapsoriasis-A Diagnosis with an Identity Crisis: A Narrative Review.

Authors:  Manasmon Chairatchaneeboon; Kanchalit Thanomkitti; Ellen J Kim
Journal:  Dermatol Ther (Heidelb)       Date:  2022-04-15

3.  An evaluation of the treatment of parapsoriasis with phototherapy.

Authors:  Ida Alzira Gomes Duarte; Karen Levy Korkes; Vanessa Alice M Amorim; Clarice Kobata; Roberta Buense; Rosana Lazzarini
Journal:  An Bras Dermatol       Date:  2013 Mar-Apr       Impact factor: 1.896

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.